Is Medicare’s Proposed Rule Violating Obamacare?
In a letter to Senate Finance Committee Chairman Charles Grassley, R-IA, a group of health providers and patient advocates expressed
Read More
Part D/Prescription Drugs
Medicare Part D Spending on Compounded Drugs up 625 Percent
In a report released Wednesday by the Office of the Inspector General at the US Health & Human Services, finds
Read MoreFilling A Prescription? You Might Be Better Off Paying Cash
(By Julie Appleby for Kaiser Health News) Some consumers who use health insurance copays to buy prescription drugs are paying
Read MoreCalls for Patient-Centered, Value-Driven Health Care
In the opinion column “Let’s Keep Progress on Cancer Moving” on the Morning Consult website, Stephen Ubl, chief executive officer
Read MoreThe Administration to Help the Supreme Court Decide on a Case
The U.S. Supreme Court has asked the Obama administration for its views on a rule (Biologics Price Competition and Innovation
Read MoreWhat is the March-In Right
Currently under federal law, The march-in right allows the US National Institutes of Health (NIH) to require a drug maker
Read MoreWhat is Step Therapy?
Step therapy as defined by North Carolina’s bill (House Bill 1048 passed by the House, but not the Senate) an
Read MoreReport From Key Calif. Agency Raises Concerns About Proposal To Cut Drug Prices
(By Cynthia H. Craft for Kaiser Health News) Researchers at one of the nation’s largest public sector health care purchasers
Read MoreAdvisory Panel Targets Rising Medicare Drug Costs In Its Latest Report To Congress
(By Julie Appleby for Kaiser Health News) Congress should move to slow spending in Medicare’s drug benefit by adopting a
Read MoreGetting Generic Drugs to the Market
On Tuesday, four U.S. Senators introduced a bill aimed at preventing big pharmaceutical companies from using the Food and Drug
Read More